{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:25:56Z","timestamp":1786119956677,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","funder":[{"name":"Shanghai Municipal Key Clinical Specialty","award":["shslczdzk03401"],"award-info":[{"award-number":["shslczdzk03401"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study was aimed at evaluating the significance of\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose PET\/computed tomography (FDG PET\/CT) in the staging and differentiation of malignant peritoneal mesothelioma (MPeM).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively analyzed clinical and imaging data of 21 women and 21 men with MPeM who underwent\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT, and reviewed and analyzed\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT characteristics of the patients. Standardized uptake values (SUV\n                      <jats:sub>max<\/jats:sub>\n                      ), metabolic tumor volume (MTV), and total lesion glycolysis (TLG = MTV \u00d7 SUV\n                      <jats:sub>mean<\/jats:sub>\n                      ) were determined for peritoneal lesions at the highest glycolysis point. Two experienced readers assessed tumor-node-metastasis (TNM) staging and peritoneal cancer index according to Peritoneal Surface Oncology Group International diagnostic requirements.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The SUV\n                      <jats:sub>max<\/jats:sub>\n                      and MTV values were significantly lower for the epithelial cases than for the nonepithelioid cases, with the difference being significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.05). The mean TLG value was significantly lower for the epithelial cases than for the nonepithelioid cases; however, the difference was NS (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&gt;\u20050.05). Exploratory laparotomy was performed in 18 patients, the\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT diagnostic accuracy for the T stage was 72.2%, and the TNM stage diagnostic accuracy was 94.4%. However, lymph node metastasis was more common in the biphasic type group, and metastasis was more often seen in the sarcomatoid type group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Using a previously suggested novel approach for TNM staging in\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT assessment of MPeM may improve the accuracy of staging; however, SUV\n                      <jats:sub>max<\/jats:sub>\n                      values showed slight variations depending on the pathology type.\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT can improve the accuracy of TNM staging, and SUV\n                      <jats:sub>max<\/jats:sub>\n                      values vary slightly depending on the pathology type. Furthermore,\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT can afford simultaneous visualization of lesions throughout the body, which can help develop a treatment strategy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mnm.0000000000001990","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T03:00:09Z","timestamp":1746500409000},"page":"746-752","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Significance of 18F-fluorodeoxyglucose PET\/computed tomography in the initial staging of malignant peritoneal mesothelioma"],"prefix":"10.1097","volume":"46","author":[{"given":"Hui","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Zhongshan Hospital (Xiamen), Fudan University, Fujian"},{"name":"Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, Fujian"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai"},{"name":"Nuclear Medicine Institute of Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beilei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Zhongshan Hospital (Xiamen), Fudan University, Fujian"},{"name":"Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, Fujian"},{"name":"Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai"},{"name":"Nuclear Medicine Institute of Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Zhongshan Hospital (Xiamen), Fudan University, Fujian"},{"name":"Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, Fujian"},{"name":"Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai"},{"name":"Nuclear Medicine Institute of Fudan University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"R1-20250709","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/PAP.0000000000000386","article-title":"Imaging of malignant pleural, pericardial, and peritoneal mesothelioma.","volume":"30","author":"Strange","year":"2023","journal-title":"Adv Anat Pathol"},{"key":"R2-20250709","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/j.semnuclmed.2022.07.005","article-title":"FDG PET\/CT for staging and restaging malignant mesothelioma.","volume":"52","author":"Lopci","year":"2022","journal-title":"Semin Nucl Med"},{"key":"R3-20250709","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.3748\/wjg.v20.i33.11700","article-title":"Advances in the management of peritoneal mesothelioma.","volume":"20","author":"Raza","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R4-20250709","doi-asserted-by":"crossref","first-page":"654","DOI":"10.21873\/cdp.10156","article-title":"Malignant peritoneal mesothelioma features shown by FDG-PET\/CT.","volume":"2","author":"Kuribayashi","year":"2022","journal-title":"Cancer Diagn Progn"},{"key":"R5-20250709","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2484\/rcr.v7i2.539","article-title":"Malignant peritoneal mesothelioma presenting as a complex omental lesion.","volume":"7","author":"Sudanthiram","year":"2015","journal-title":"Radiol Case Rep"},{"key":"R6-20250709","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cncr.25640","article-title":"A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database.","volume":"117","author":"Yan","year":"2011","journal-title":"Cancer"},{"key":"R7-20250709","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/RLU.0000000000002901","article-title":"18F-FDG uptake of localized malignant peritoneal mesothelioma.","volume":"45","author":"Kodama","year":"2020","journal-title":"Clin Nucl Med"},{"key":"R8-20250709","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13139-015-0360-2","article-title":"Malignant peritoneal mesothelioma masquerades as peritoneal metastasis on (18)F-FDG PET\/CT scans; a rare diagnosis that should not be missed.","volume":"49","author":"Claimon","year":"2015","journal-title":"Nucl Med Mol Imaging"},{"key":"R9-20250709","first-page":"54","article-title":"Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma.","volume":"60","author":"Dom\u00e8nech-Vilardell","year":"2016","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R10-20250709","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0.","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-20250709","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis.","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"key":"R12-20250709","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejrad.2017.05.036","article-title":"F-18 FDG PET\/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer.","volume":"93","author":"Gallicchio","year":"2017","journal-title":"Eur J Radiol"},{"key":"R13-20250709","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12935-022-02482-5","article-title":"Prognostic value of maximum standard uptake value, metabolic tumour volume, and total lesion glycolysis of 18F-FDG PET\/CT in patients with malignant pleural mesothelioma: a systematic review and meta-analysis.","volume":"22","author":"Wen","year":"2022","journal-title":"Cancer Cell Int"},{"key":"R14-20250709","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MNM.0000000000000649","article-title":"The role of 18F-FDG-PET\/ceCT in peritoneal mesothelioma.","volume":"38","author":"Dubreuil","year":"2017","journal-title":"Nucl Med Commun"},{"key":"R15-20250709","first-page":"3","article-title":"The efficacy of 18F-FDG PET\/CT in monitoring disease progression in malignant pleural mesothelioma.","volume":"42","author":"S\u00f6yler","year":"2023","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"key":"R16-20250709","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ctrv.2012.12.005","article-title":"Malignant mesothelioma: new insights into a rare disease.","volume":"39","author":"Remon","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"R17-20250709","doi-asserted-by":"crossref","first-page":"e013324","DOI":"10.1136\/bmjopen-2016-013324","article-title":"Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study.","volume":"6","author":"Tsim","year":"2016","journal-title":"BMJ Open"},{"key":"R18-20250709","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/diagnostics13111974","article-title":"Peritoneal carcinosis: what the radiologist needs to know.","volume":"13","author":"Reginelli","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R19-20250709","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2214\/ajr.150.5.1035","article-title":"CT manifestations of peritoneal carcinomatosis.","volume":"150","author":"Walkey","year":"1988","journal-title":"AJR Am J Roentgenol"},{"key":"R20-20250709","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/jgh.13260","article-title":"CT differentiation of diffuse malignant peritoneal mesothelioma and peritoneal carcinomatosis.","volume":"31","author":"Liang","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"R21-20250709","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00104-022-01754-0","article-title":"[Peritoneal carcinomatosis].","volume":"93","author":"Bruns","year":"2022","journal-title":"Chirurgie (Heidelb)"},{"key":"R22-20250709","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11547-015-0609-y","article-title":"CT differentiation of malignant peritoneal mesothelioma and tuberculous peritonitis.","volume":"121","author":"Yin","year":"2016","journal-title":"Radiol Med"},{"key":"R23-20250709","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00261-022-03464-x","article-title":"The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review.","volume":"47","author":"Carlson","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"R24-20250709","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2008-1039314","article-title":"The role of positron emission tomography\/computed tomography in the diagnosis of pleural diseases.","volume":"57","author":"Orki","year":"2009","journal-title":"Thorac Cardiovasc Surg"},{"key":"R25-20250709","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11604-016-0555-1","article-title":"Present and future roles of FDG-PET\/CT imaging in the management of malignant pleural mesothelioma.","volume":"34","author":"Kitajima","year":"2016","journal-title":"Jpn J Radiol"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000001990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:30:47Z","timestamp":1786044647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000001990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000001990","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]}}}